Overview

Patient Satisfaction and Quality of Life Impact - PecFent®

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
National multicenter, prospective, observational study in cancer patients with chronic background pain and breakthrough pain to whom PecFent® has been prescribed under pragmatic condition by a specialist in the treatment of cancer pain conditions. • Study objectives include assessment of early treatment satisfaction.
Details
Lead Sponsor:
Archimedes Development Ltd
Treatments:
Fentanyl